Health & Environmental Research Online (HERO)


Print Feedback Export to File
3856465 
Journal Article 
Exposure of pregnant mice to perfluorobutanesulfonate causes hypothyroxinemia and developmental abnormalities in female offspring 
Feng, X; Cao, X; Zhao, S; Wang, X; Hua, X; Chen, L; Chen, L 
2017 
Yes 
Toxicological Sciences
ISSN: 1096-6080
EISSN: 1096-0929 
155 
409-419 
English 
Perfluorobutanesulfonate (PFBS) is widely used in many industrial products. We evaluated the influence of prenatal PFBS exposure on perinatal growth and development, pubertal onset, and reproductive and thyroid endocrine system in female mice. Here, we show that when PFBS (200 and 500 mg/kg/day) was orally administered to pregnant mice (PFBS-dams) on days 1-20 of gestation; their female offspring (PFBS-offspring) exhibited decreased perinatal body weight and delayed eye opening compared with control offspring. Vaginal opening and first estrus were also significantly delayed in PFBS-offspring, and diestrus was prolonged. Ovarian and uterine size, as well as follicle and corpus luteum numbers, were reduced in adult PFBS-offspring. Furthermore, pubertal and adult PFBS-offspring exhibited decreases in serum estrogen (E2) and progesterone (P4) levels with the elevation of luteinizing hormone levels. Notably, decreases in serum total thyroxine (T4) and 3,3', 5-triiodothyronine (T3) levels were observed in fetal, pubertal, and adult PFBS-offspring in conjunction with slight increases in thyroid-stimulating hormone (TSH) and thyrotropin-releasing hormone levels. In addition, PFBS-dams exhibited significant decreases in total T4 and T3 levels and free T4 levels and increases in TSH levels, but no changes in E2 and P4 levels. These results indicate that prenatal PFBS exposure (≥200 mg/kg/day) causes permanent hypothyroxinemia accompanied by deficits in perinatal growth, pubertal onset, and reproductive organ development in female mice. 
perfluorobutanesulfonate; hypothyroxinemia; estrogen; pubertal onset; ovary; uterus 
IRIS
• SR Automation
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFOA (335-67-1) and PFOS (1763-23-1)
          Literature Search – Adverse outcome pathway (2015-present)
               WOS
     PFBS (375-73-5)
          Literature Search
               Pubmed
               WOS
• PFBS
          Pubmed
          WOS
          In vivo animal studies
               Repro tox
               Developmental tox
     Search
          PubMed
          WOS
     Included
          Met PECO Criteria
               Animal
          WOS
• PFNA
     Literature Search
          Toxline
     PFNA May 2019 Update
          Toxnet
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search – Adverse outcome pathway (2015-present)
          WOS
     Screening Results
          In vivo animal studies
               Developmental tox
               Thyroid bioactivity
     Literature Search Update (2013-2019)
          WOS